11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Other Events
Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
News, Articles of Incorporation
Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
Aethlon Medical Files Amendment to Prospectus Supplement for Common Stock
Stockholders Approve Amendment to 2020 Equity Incentive Plan
Q1
FY 2025
Q3
Q2
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence
Withdrawal of Offering Statement